Author archives: Matthew Woodruff

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the…

FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19

An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health official…